@OzmosiHealth OzmosiOzmosi posts on X about more info, $xbi, $xph, $ibb the most. They currently have [-----] followers and [-----] posts still getting attention that total [-----] engagements in the last [--] hours.
Social category influence stocks countries finance cryptocurrencies currencies technology brands automotive brands travel destinations exchanges social networks
Social topic influence more info #237, $xbi, $xph, $ibb, $pph, $mrk, $bmy, gainers, $lly #93, canada
Top accounts mentioned or mentioned by @biomedicalrx @galenlittle @hawkeyethenoop @crisprglenn @wallstreet_dawg
Top assets mentioned Merck & Co., Inc. (MRK) Bristol-Myers Squibb Co (BMY) Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) AstraZeneca PLC (AZN) AbbVie Inc (ABBV) Pfizer, Inc. (PFE) Arvinas, Inc (ARVN) Athira Pharma, Inc. (ATHA) Incyte Corporation (INCY) Axsome Therapeutics, Inc (AXSM) ImmunityBio, Inc. Common Stock (IBRX) Inventiva S.A. (IVA) Roivant Sciences Ltd. Common Shares (ROIV) Biogen Inc (BIIB) Gilead Sciences, Inc. (GILD) Geron Corp (GERN) Neurocrine Biosciences, Inc. (NBIX) Sanofi (SNY) Ocular Therapeutix, Inc. (OCUL) TG Therapeutics, Inc. (TGTX) Corcept Therapeutics Inc. (CORT) Nuvation Bio Inc. (NUVB) Amgen, Inc. (AMGN) Ionis Pharmaceuticals, Inc. Common Stock (IONS) SuperRare (RARE) BridgeBio Pharma, Inc. Common Stock (BBIO) Cytokinetics Inc. (CYTK) Synthetify (SNY) IDEAYA Biosciences, Inc. Common Stock (IDYA) 4D Molecular Therapeutics Inc. (FDMT) Regeneron Pharmaceuticals Inc (REGN) Amphastar Pharmaceuticals, Inc. (AMPH) Apellis Pharmaceuticals, Inc. Common Stock (APLS) Alnylam Pharmaceuticals, Inc. (ALNY) Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Biomea Fusion, Inc. (BMEA) Origin Protocol (OGN) Kymera Therapeutics, Inc. (KYMR) Intra-Cellular Therapies Inc. (ITCI) Celldex Therapeutics, Inc (CLDX) Viking Therapeutics, Inc (VKTX) Bluefin (BLUE) Nuvalent, Inc. (NUVL) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Travere Therapeutics, Inc. Common Stock (TVTX) Jazz Pharmaceuticals, Inc. (JAZZ) PTC Therapeutics, Inc. (PTCT) Novavax Inc (NVAX) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Atea Pharmaceuticals, Inc. (AVIR) Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) Catalent Inc (CTLT) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Zentalis Pharmaceuticals, LLC (ZNTL) Novartis AG (NVS) BEAM (BEAM) Intellia Therapeutics, Inc (NTLA) Vertex Protocol (VRTX)
Top posts by engagements in the last [--] hours
"$LEGN Legend Biotech Appoints Carlos Santos as Chief Financial Officer"
X Link 2025-08-18T20:45Z [----] followers, [---] engagements
"$GANX Gain Therapeutics shares more preclinical data and outlines Phase 1b study for GT-02287 at AD/PD [----] also provides enrollment status update. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/23956 https://pryzm.ozmosi.com/product/23956"
X Link 2025-04-10T11:02Z [----] followers, [---] engagements
"$GANX Gain Therapeutics Reports Financial Results for Second Quarter [----] and Provides Corporate Update"
X Link 2025-08-12T13:34Z [----] followers, [---] engagements
"$EVAX Evaxion Biotech announced they will present P2 Melanoma results on 2025-10-17 for EVX-01 More Info: https://pryzm.ozmosi.com/product/25443 https://pryzm.ozmosi.com/product/25443"
X Link 2025-08-28T20:51Z [----] followers, [---] engagements
"$GANX GAIN Therapeutics announced they will present Phase [--] Movement DisordersParkinson's Disease results on 2025-10-07 for GT-02287 More Info: https://pryzm.ozmosi.com/product/23956 https://pryzm.ozmosi.com/product/23956"
X Link 2025-09-19T20:19Z [----] followers, [---] engagements
"$GANX +7.36% today as Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson's Patients at International Congress of Parkinson's Disease and Movement Disorders More Info: https://pryzm.ozmosi.com/product/23956 https://pryzm.ozmosi.com/product/23956"
X Link 2025-10-06T13:47Z [----] followers, [---] engagements
"$EVAX Evaxion Biotech announced they will present Phase [--] Melanoma results on 2025-10-17 for EVX-01 More Info: https://pryzm.ozmosi.com/product/25443 https://pryzm.ozmosi.com/product/25443"
X Link 2025-10-06T20:04Z [----] followers, [---] engagements
"$EVAX Evaxion Biotech announced they will present Phase [--] Melanoma results on 2025-11-07 for EVX-01 More Info: https://pryzm.ozmosi.com/product/25443 https://pryzm.ozmosi.com/product/25443"
X Link 2025-10-06T20:04Z [----] followers, [---] engagements
"$GANX -0.48% today as Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson's Disease More Info: https://pryzm.ozmosi.com/product/23956 https://pryzm.ozmosi.com/product/23956"
X Link 2025-10-09T13:39Z [----] followers, [---] engagements
"$EVAX Evaxion Biotech announced they will present Phase [--] Melanoma results on 2025-10-17 for EVX-01 More Info: https://pryzm.ozmosi.com/product/25443 https://pryzm.ozmosi.com/product/25443"
X Link 2025-10-14T21:49Z [----] followers, [---] engagements
"ππ¨ BIOPHARM CATALYST ALERT π $GANX GAIN Therapeutics will present Unknown Parkinson's Disease Data for GT-02287 (GCase Enhancer - Small Molecule) tomorrow π"
X Link 2025-11-18T11:12Z [----] followers, [---] engagements
"$BRNS +7.75% today as Barinthus Bio Announces Update on Phase [--] AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease More Info: https://pryzm.ozmosi.com/product/27012 https://pryzm.ozmosi.com/product/27012"
X Link 2025-12-10T14:42Z [----] followers, [---] engagements
"$GHRS GH Research Announces FDA Lifts Clinical Hold on GH001 Clearing Path for Global Phase [--] Initiation in [----] More Info: https://pryzm.ozmosi.com/product/26166 https://pryzm.ozmosi.com/product/26166"
X Link 2026-01-05T14:03Z [----] followers, [---] engagements
"After years of delay Novartis' Sandoz finally wins Neulasta biosimilar FDA approval $NVS #pharma #cancer https://buff.ly/2COfWPX https://buff.ly/2COfWPX"
X Link 2019-11-12T16:09Z [----] followers, [--] engagements
"AstraZenecas Alexion concludes Caelum acquisition for $500m #MnA $AZN $ALXN #RareDisease https://buff.ly/3ahd9PK https://buff.ly/3ahd9PK"
X Link 2021-10-07T12:53Z [----] followers, [--] engagements
"ImmunityBio announces acquisition of leasehold interest of new state of the art biotech production facility in Dunkirk NY $IBRX now has ability to expand manufacturing capacity in United States $IRBX is up 21% today π"
X Link 2022-02-15T19:32Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AMPH (Amphastar Pharma) 1.49% π $COLL (Collegium Pharmaceutical) 2.09% π $PFE (Pfizer) 3.92% π Top [--] XPH Laggards: $NKTR (Nektar Ther) -60.87% π» $AXSM (Axsome Ther) -12.78% π» $AERI (Aerie Pharma) -10.61% π»"
X Link 2022-03-14T20:05Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $HRMY (Harmony Biosciences) 5.59% π $AVIR (Atea Pharma) 6.33% π $TBPH (Theravance Biopharma) 6.92% π Top [--] XPH Laggards: $ANIP (ANI Pharma) -10.1% π» $AERI (Aerie Pharma) -3.9% π» $AMPH (Amphastar Pharma) -2.4% π»"
X Link 2022-03-16T18:24Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AERI (Aerie Pharma) 5.76% π $MRNS (Marinus Pharma) 5.95% π $NGM (NGM Biopharma) 6.25% π Top [--] XPH Laggards: $CORT (Corcept Ther) -3.7% π» $PFE (Pfizer) -2.3% π» $AMPH (Amphastar Pharma) -2.2% π»"
X Link 2022-03-22T15:20Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ESPR (Esperion Ther) 5.06% π $ENDP (Endo International) 5.14% π $AXSM (Axsome Ther) 7.38% π Top [--] XPH Laggards: $AMPH (Amphastar Pharma) -0.9% π» $LLY (Eli Lilly and Co) -0.8% π» $BMY (Bristol-Myers Squibb) -0.5% π»"
X Link 2022-03-29T13:47Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $PCRX (Pacira BioSciences) 2.94% π $AMPH (Amphastar Pharma) 4.25% π $FULC (Fulcrum Ther) 4.35% π Top [--] XPH Laggards: $NUVB (Nuvation Bio) -6.7% π» $SAVA (Cassava Sciences) -4.7% π» $NGM (NGM Biopharma) -4.1% π»"
X Link 2022-04-07T14:25Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ACRS (Aclaris Ther) 1.17% π $PAHC (Phibro Animal Health) 1.81% π $AMPH (Amphastar Pharma) 3.03% π Top [--] XPH Laggards: $FULC (Fulcrum Ther) -11.7% π» $PCRX (Pacira BioSciences) -10.4% π» $MRNS (Marinus Pharma) -8.2% π»"
X Link 2022-04-11T16:13Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $RPRX (Royalty Pharma) -0.26% π $PBH (Prestige Consumer Healthcare) -0.17% π $ATRS (Antares Pharma) 0.09% π Top [--] XPH Laggards: $NKTR (Nektar Ther) -35.1% π» $AXSM (Axsome Ther) -7.1% π» $ESPR (Esperion Ther) -6.6% π»"
X Link 2022-04-18T14:43Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $NUVB (Nuvation Bio) 1.06% π $SUPN (Supernus Pharma) 1.41% π $PBH (Prestige Consumer Healthcare) 2.26% π Top [--] XPH Laggards: $FULC (Fulcrum Ther) -4.4% π» $NGM (NGM Biopharma) -3.1% π» $OMER (Omeros) -3.0% π»"
X Link 2022-04-20T13:37Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ELAN (Elanco Animal Health) 1.61% π $RVNC (Revance Ther) 3.32% π $SAVA (Cassava Sciences) 5.67% π Top [--] XPH Laggards: $ITCI (Intra-Cellular Ther) -5.7% π» $ENDP (Endo International) -3.6% π» $CARA (Cara Ther) -2.8% π»"
X Link 2022-04-22T13:58Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $OMER (Omeros) 0.3% π $PBH (Prestige Consumer Healthcare) 0.61% π $ATHA (Athira Pharma) 0.75% π Top [--] XPH Laggards: $AMRX (Amneal Pharma) -15.7% π» $ENDP (Endo) -7.7% π» $NGM (NGM Biopharma) -7.2% π»"
X Link 2022-05-04T14:19Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $MRK (Merck & Co) 0.62% π $PAHC (Phibro Animal Health) 1.0% π $PBH (Prestige Consumer Healthcare) 1.85% π Top [--] XPH Laggards: $ENDP (Endo) -30.2% π» $AXSM (Axsome Ther) -11.2% π» $CORT (Corcept Ther) -7.7% π»"
X Link 2022-05-06T15:05Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $VNDA (Vanda Pharma) 3.75% π $MRNA (Moderna) 4.15% π $FOLD (Amicus Ther.) 6.7% π Top [--] XBI Laggards: $STRO (Sutro Biopharma) -11.7% π» $EDIT (Editas Medicine) -11.6% π» $GBT (Global Blood Ther.) -9.2% π»"
X Link 2022-05-09T14:22Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ITCI (Intra-Cellular Ther) 16.53% π $NUVB (Nuvation Bio) 16.67% π $CARA (Cara Ther) 18.26% π Top [--] XPH Laggards: $FULC (Fulcrum Ther) -6.8% π» $ESPR (Esperion Ther) -4.1% π» $ENDP (Endo) -2.9% π»"
X Link 2022-05-10T15:02Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $FOLD (Amicus Ther.) 8.03% π $ITOS (ITeos Ther.) 8.83% π $CGEM (Cullinan Oncology) 19.43% π Top [--] XBI Laggards: $YMAB (Y-mAbs Ther.) -10.7% π» $CHRS (Coherus Bio) -3.6% π» $ISEE (IVERIC bio) -3.6% π»"
X Link 2022-05-12T14:04Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $COLL (Collegium Pharma) 3.89% π $FULC (Fulcrum Ther) 4.76% π $AVIR (Atea Pharma) 5.32% π Top [--] XPH Laggards: $ENDP (Endo) -4.3% π» $PBH (Prestige Consumer Healthcare) -2.9% π» $PRVB (Provention Bio) -2.6% π»"
X Link 2022-05-19T15:34Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AMPH (Amphastar Pharma) 3.5% π $SAVA (Cassava Sciences) 5.76% π $TBPH (Theravance Biopharma) 5.84% π Top [--] XPH Laggards: $AXSM (Axsome Ther) -7.7% π» $RVNC (Revance Ther) -7.3% π» $ENDP (Endo) -5.9% π»"
X Link 2022-05-23T15:35Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $CDMO (Avid Bioservices) 2.23% π $UTHR (United Ther.) 3.27% π $QURE (uniQure NV) 3.44% π Top [--] XBI Laggards: $CMRX (Chimerix) -20.6% π» $BTAI (BioXcel Ther.) -12.4% π» $SWTX (SpringWorks Ther.) -11.9% π»"
X Link 2022-05-24T16:36Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AMPH (Amphastar Pharma) 6.36% π $ENDP (Endo) 7.81% π $ATRS (Antares Pharma) nan% π Top [--] XPH Laggards: $FULC (Fulcrum Ther) -5.7% π» $AERI (Aerie Pharma) -5.6% π» $AXSM (Axsome Ther) -4.8% π»"
X Link 2022-05-25T17:08Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ENDP (Endo) 2.77% π $AMPH (Amphastar Pharma) 5.25% π $PBH (Prestige Consumer Healthcare) nan% π Top [--] XPH Laggards: $ITCI (Intra-Cellular Ther) -4.6% π» $AXSM (Axsome Ther) -2.4% π» $AMRX (Amneal Pharma) -2.3% π»"
X Link 2022-05-27T13:41Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $FULC (Fulcrum Ther) 9.43% π $OMER (Omeros) 10.5% π $AMPH (Amphastar Pharma) 11.72% π Top [--] XPH Laggards: $ENDP (Endo) -5.7% π» $CORT (Corcept Ther) -1.7% π» $AVIR (Atea Pharma) -1.0% π»"
X Link 2022-06-07T15:46Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ROIV (Roivant Sciences) 8.3% π $AMRX (Amneal Pharma) 8.79% π $ENDP (Endo International) 8.9% π Top [--] XPH Laggards: $AVIR (Atea Pharma) -1.0% π» $CORT (Corcept Ther.) -0.8% π» $AMPH (Amphastar Pharma) -0.8% π»"
X Link 2022-06-15T16:12Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $RVNC (Revance Ther.) 7.21% π $FULC (Fulcrum Ther.) 9.35% π $OMER (Omeros) 15.3% π Top [--] XPH Laggards: $ATHA (Athira Pharma) -65.0% π» $ACRS (Aclaris Ther.) -1.2% π» $ITCI (Intra-Cellular Therapies) -0.3% π»"
X Link 2022-06-22T16:01Z [----] followers, [--] engagements
"π¬ Drugs w/Novel Mechanism & Primary Completion Date Today π
$AZN tozorakimab (IL33 Inhibitor) by AstraZeneca in P2 - NCT04570657 $RLAY rly-1971 (SHP-2 Inhibitor) by Hoffmann-La Roche in P1 - NCT04252339"
X Link 2022-06-27T14:16Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AMPH (Amphastar Pharma) 6.39% π $OMER (Omeros) 7.85% π $AXSM (Axsome Ther.) 43.87% π Top [--] XPH Laggards: $NUVB (Nuvation Bio) -13.2% π» $PAHC (Phibro Animal Health) -5.3% π» $ROIV (Roivant Sciences) -4.1% π»"
X Link 2022-06-27T16:39Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AMPH (Amphastar Pharma) 2.12% π $ZTS (Zoetis) 2.16% π $ITCI (Intra-Cellular Therapies) 3.66% π Top [--] XPH Laggards: $ENDP (Endo International) -20.6% π» $OMER (Omeros) -8.6% π» $COLL (Collegium Pharma) -3.6% π»"
X Link 2022-06-29T16:10Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $RIGL (Rigel Pharma) 9.73% π $AKBA (Akebia Ther.) 9.75% π $KZR (Kezar Life Sciences) 11.61% π Top [--] XBI Laggards: $CLDX (Celldex Ther.) -15.0% π» $SRRK (Scholar Rock) -4.4% π» $ISEE (IVERIC bio) -3.8% π»"
X Link 2022-07-01T18:20Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $OCUL (Ocular Ther.) 1.66% π $PAHC (Phibro Animal Health) 2.5% π $PBH (Prestige Co) nan% π Top [--] XPH Laggards: $TBPH (Theravance Biopharma) -5.0% π» $FULC (Fulcrum Ther.) -4.0% π» $NKTR (Nektar Ther.) -3.8% π»"
X Link 2022-07-12T13:40Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ENDP (Endo International) 5.93% π $OMER (Omeros) 6.39% π $FULC (Fulcrum Ther.) 6.64% π Top [--] XPH Laggards: $MRK (Merck & Co) -2.3% π» $INVA (Innoviva) -2.1% π» $AMPH (Amphastar Pharma) -2.0% π»"
X Link 2022-07-20T15:39Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ITCI (Intra-Cellular Therapies) 1.92% π $ATHA (Athira Pharma) 3.38% π $NKTR (Nektar Ther.) 3.76% π Top [--] XPH Laggards: $NUVB (Nuvation Bio) -4.1% π» $RETA (Reata Pharma) -3.0% π» $RLMD (Relmada Ther.) -2.7% π»"
X Link 2022-07-26T16:03Z [----] followers, [--] engagements
"$CERE Cerevel Therapeutics Reports Second Quarter [----] Financial Results and Business Updates https://www.benzinga.com/pressreleases/22/08/g28285355/cerevel-therapeutics-reports-second-quarter-2022-financial-results-and-business-updates https://www.benzinga.com/pressreleases/22/08/g28285355/cerevel-therapeutics-reports-second-quarter-2022-financial-results-and-business-updates"
X Link 2022-08-01T20:09Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ROIV (Roivant Sciences) 3.55% π $AERI (Aerie Pharma) 3.85% π $CARA (Cara Ther.) 5.74% π Top [--] XPH Laggards: $ENDP (Endo International) -36.9% π» $AMPH (Amphastar Pharma) -13.0% π» $RVNC (Revance Ther.) -9.5% π»"
X Link 2022-08-09T15:57Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AERI (Aerie Pharma) 5.77% π $PRVB (Provention Bio) 8.43% π $FULC (Fulcrum Ther.) 10.7% π Top [--] XPH Laggards: $ITCI (Intra-Cellular Therapies) -4.0% π» $OGN (Organon & Co) -2.1% π» $ENDP (Endo International) -2.0% π»"
X Link 2022-08-12T15:23Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $KRYS (Krystal Biotech) 3.63% π $BPMC (Blueprint Medicines) 3.96% π $TPTX (Turning Point Ther.) nan% π Top [--] XBI Laggards: $IBRX (ImmunityBio) -7.8% π» $SANA (Sana Biotech) -7.5% π» $SWTX (SpringWorks Ther.) -6.9% π»"
X Link 2022-08-19T14:09Z [----] followers, [--] engagements
"Editas Medicine Recent Pipeline Updates $EDIT makes up .9% of the $XBI #CRISPR"
X Link 2022-08-25T15:09Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ITCI (Intra-Cellular Therapies) 2.15% π $SAVA (Cassava Sciences) 6.49% π $ENDP (Endo International) nan% π Top [--] XPH Laggards: $OCUL (Ocular Ther.) -6.9% π» $ACRS (Aclaris Ther.) -6.0% π» $ARVN (Arvinas) -5.8% π»"
X Link 2022-08-26T17:12Z [----] followers, [--] engagements
"Immunocore $IMCR falls 20% π»despite their announcement that IMC-F106C a PRAMECD3 ImmTAC activated T cells & was well tolerated in patients in a P1 trial at #ESMO2022. #stocks #biotech"
X Link 2022-09-09T17:06Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $PBH (Prestige Co) 0.8% π $TBPH (Theravance Biopharma) 3.08% π $ACRS (Aclaris Ther.) 3.19% π Top [--] XPH Laggards: $AVIR (Atea Pharma) -9.8% π» $NUVB (Nuvation Bio) -5.5% π» $PRVB (Provention Bio) -4.0% π»"
X Link 2022-09-19T15:41Z [----] followers, [--] engagements
"π₯Companies with important clinical readouts Coming soonπ
$PCSA Eniluracil (DPD Inhibitor) by Processa Pharma in P1 - NCT04861987 $PMVP PC-14586 (p53 Activator) by PMV Pharma in P1 - NCT05249348 $AZD Tozorakimab (IL33 Inhibitor) by AstraZeneca in P2 - NCT04212169"
X Link 2022-09-20T16:27Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $NVAX (Novavax) 8.11% π $BBIO (BridgeBio Pharma) 8.54% π $VERV (Verve Ther.) 11.43% π Top [--] XBI Laggards: $RNA (Avidity Bio) -14.7% π» $ALXO (ALX Oncology) -3.8% π» $DMTK (DermTech) -3.7% π»"
X Link 2022-09-27T16:04Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ACRS (Aclaris Ther.) 3.5% π $ITCI (Intra-Cellular Therapies) 3.54% π $PRVB (Provention Bio) 4.51% π Top [--] XPH Laggards: $OCUL (Ocular Ther.) -8.3% π» $PRGO (Perrigo Co) -2.9% π» $FULC (Fulcrum Ther.) -2.0% π»"
X Link 2022-09-27T16:07Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $PBH (Prestige Co) 1.17% π $JAZZ (Jazz Pharma) 2.24% π $RLMD (Relmada Ther.) 2.82% π Top [--] XPH Laggards: $OMER (Omeros) -7.2% π» $NKTR (Nektar Ther.) -5.6% π» $FULC (Fulcrum Ther.) -4.7% π»"
X Link 2022-09-29T16:21Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ITCI (Intra-Cellular Therapies) 1.63% π $OCUL (Ocular Ther.) 3.53% π $PRVB (Provention Bio) 10.61% π Top [--] XPH Laggards: $OMER (Omeros) -5.8% π» $AXSM (Axsome Ther.) -5.3% π» $NKTR (Nektar Ther.) -3.8% π»"
X Link 2022-10-07T14:07Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $AMGN (Amgen) 7.12% π $NVAX (Novavax) 9.56% π $ALBO (Albireo Pharma) 22.18% π Top [--] XBI Laggards: $RIGL (Rigel Pharma) -20.5% π» $BPMC (Blueprint Medicines) -3.8% π» $AKBA (Akebia Ther.) -3.3% π»"
X Link 2022-10-11T15:11Z [----] followers, [--] engagements
"π₯Companies with important clinical readouts Coming soonπ
$AMG Efavaleukin alfa (IL2 Agonist) by Amgen in P2 - NCT03422627 $NVS NZV-930 (CD73 Inhibitor) by Novartis in P1 - NCT03549000 $SGIOY Ensitrelvir (3CLpro Inhibitor) by Shionogi in P3 - NCT05305547"
X Link 2022-10-13T16:43Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $PRVB (Provention Bio) 3.58% π $RLMD (Relmada Ther.) 4.72% π $NGM (NGM Biopharma) 21.92% π Top [--] XPH Laggards: $FULC (Fulcrum Ther.) -14.9% π» $ITCI (Intra-Cellular Therapies) -3.6% π» $PCRX (Pacira BioSciences) -3.6% π»"
X Link 2022-10-20T17:43Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ATHA (Athira Pharma) 3.8% π $AMPH (Amphastar Pharma) 4.47% π $PFE (Pfizer) 4.58% π Top [--] XPH Laggards: $RLMD (Relmada Ther.) -5.7% π» $AXSM (Axsome Ther.) -4.1% π» $OCUL (Ocular Ther.) -3.8% π»"
X Link 2022-10-21T16:10Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ANIP (ANI Pharma) 2.74% π $LLY (Eli Lilly and Co) 2.76% π $HRMY (Harmony Biosciences) 2.87% π Top [--] XPH Laggards: $RLMD (Relmada Ther.) -6.3% π» $FULC (Fulcrum Ther.) -6.1% π» $ITCI (Intra-Cellular Therapies) -4.9% π»"
X Link 2022-10-24T19:27Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $FULC (Fulcrum Ther.) 5.69% π $RLMD (Relmada Ther.) 6.06% π $SAVA (Cassava Sciences) 6.81% π Top [--] XPH Laggards: $AMPH (Amphastar Pharma) -3.3% π» $ATHA (Athira Pharma) -2.2% π» $JNJ (Johnson & Johnson) -0.4% π»"
X Link 2022-10-25T14:13Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AMPH (Amphastar Pharma) 4.69% π $FULC (Fulcrum Ther.) 12.2% π $ARVN (Arvinas) 12.9% π Top [--] XPH Laggards: $OMER (Omeros) -6.8% π» $PRVB (Provention Bio) -1.9% π» $HRMY (Harmony Biosciences) -1.5% π»"
X Link 2022-10-26T17:32Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $MCRB (Seres Ther.) 9.52% π $AKBA (Akebia Ther.) 13.53% π $VCYT (Veracyte) 24.1% π Top [--] XBI Laggards: $RGNX (Regenxbio) -15.2% π» $SANA (Sana Biotech) -12.0% π» $EDIT (Editas Medicine) -9.8% π»"
X Link 2022-11-03T17:25Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ITCI (Intra-Cellular Therapies) 13.66% π $AXSM (Axsome Ther.) 17.6% π $PRVB (Provention Bio) 22.79% π Top [--] XPH Laggards: $ZTS (Zoetis) -11.8% π» $CTLT (Catalent) -6.6% π» $AMRX (Amneal Pharma) -3.8% π»"
X Link 2022-11-03T17:25Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AMPH (Amphastar Pharma) 3.92% π $TBPH (Theravance Biopharma) 6.18% π $FULC (Fulcrum Ther.) 7.44% π Top [--] XPH Laggards: $ANIP (ANI Pharma) -12.4% π» $ELAN (Elanco Animal Health) -7.8% π» $OCUL (Ocular Ther.) -7.3% π»"
X Link 2022-11-09T17:05Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $RLAY (Relay Ther.) 7.0% π $APLS (Apellis Pharma) 18.94% π $ISEE (IVERIC bio) 27.41% π Top [--] XBI Laggards: $GTHX (G1 Ther.) -24.0% π» $RAPT (RAPT Ther.) -14.8% π» $IOVA (Iovance BioTher.) -9.8% π»"
X Link 2022-11-18T16:45Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ITCI (Intra-Cellular Therapies) 1.65% π $FULC (Fulcrum Ther.) 3.08% π $AERI (Aerie Pharma) nan% π Top [--] XPH Laggards: $ARVN (Arvinas) -11.3% π» $OMER (Omeros) -8.3% π» $NGM (NGM Biopharma) -7.1% π»"
X Link 2022-11-21T17:39Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $GTHX (G1 Ther.) 2.92% π $CDNA (CareDx) 3.95% π $RIGL (Rigel Pharma) 5.25% π Top [--] XBI Laggards: $GOSS (Gossamer Bio) -74.0% π» $MRTX (Mirati Ther.) -19.3% π» $NVAX (Novavax) -8.9% π»"
X Link 2022-12-06T16:36Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ANIP (ANI Pharma) 3.93% π $SAVA (Cassava Sciences) 4.32% π $ROIV (Roivant Sciences) 5.53% π Top [--] XPH Laggards: $RLMD (Relmada Ther.) -48.8% π» $CTLT (Catalent) -4.2% π» $ITCI (Intra-Cellular Therapies) -3.4% π»"
X Link 2022-12-08T19:53Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ANIP (ANI Pharma) 3.92% π $SAVA (Cassava Sciences) 4.32% π $ROIV (Roivant Sciences) 5.61% π Top [--] XPH Laggards: $RLMD (Relmada Ther.) -48.8% π» $CTLT (Catalent) -4.2% π» $ITCI (Intra-Cellular Therapies) -3.4% π»"
X Link 2022-12-08T19:53Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $EXAS (Exact Sciences) 16.39% π $RIGL (Rigel Pharma) 16.54% π $GOSS (Gossamer Bio) 30.0% π Top [--] XBI Laggards: $CCCC (C4 Ther.) -9.1% π» $KRON (Kronos Bio) -8.6% π» $TGTX (TG Ther.) -8.1% π»"
X Link 2022-12-16T21:11Z [----] followers, [---] engagements
"PDS Biotech announces payment of $5 million to Merck KGaA for exclusive rights to their IL-12 fusion protein M9241 for treatment of Solid Tumors $PDSB $MKKGY #biotech #cancer #deals"
X Link 2023-01-03T16:17Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $CHRS (Coherus Bio) 14.75% π $DCPH (Deciphera Pharma) 18.04% π $GERN (Geron) 35.78% π Top [--] XBI Laggards: $TGTX (TG Ther.) -7.1% π» $AKRO (Akero Ther.) -4.7% π» $SNDX (Syndax Pharma) -4.6% π»"
X Link 2023-01-04T16:09Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $NKTR (Nektar Ther.) 5.94% π $OMER (Omeros) 7.26% π $COLL (Collegium Pharma) 7.95% π Top [--] XPH Laggards: $FULC (Fulcrum Ther.) -7.8% π» $ACRS (Aclaris Ther.) -2.5% π» $RETA (Reata Pharma) -2.1% π»"
X Link 2023-01-04T16:09Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ACRS (Aclaris Ther.) 3.27% π $FULC (Fulcrum Ther.) 4.23% π $RETA (Reata Pharma) 5.4% π Top [--] XPH Laggards: $OMER (Omeros) -5.9% π» $RLMD (Relmada Ther.) -5.1% π» $OCUL (Ocular Ther.) -4.7% π»"
X Link 2023-01-05T15:27Z [----] followers, [---] engagements
"The success of the drug will be controlled by Eisai even if Medicare covers it. They'll need to create a disease management shift and increase demand for early screening & treatment before Alzheimer's symptoms begin. Big blockbuster potential if they can do it. $ESALY $BIIB #ALZ Japanese drugmaker Eisai surges in Tokyo trading after winning initial FDA clearance for its pioneering Alzheimers treatment https://t.co/NCj1Rwk13M Japanese drugmaker Eisai surges in Tokyo trading after winning initial FDA clearance for its pioneering Alzheimers treatment https://t.co/NCj1Rwk13M"
X Link 2023-01-10T16:31Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ROIV (Roivant Sciences) 4.67% π $NUVB (Nuvation Bio) 9.31% π $FULC (Fulcrum Ther.) 10.0% π Top [--] XPH Laggards: $ANIP (ANI Pharma) -2.5% π» $NGM (NGM Biopharma) -2.3% π» $ITCI (Intra-Cellular Therapies) -2.0% π»"
X Link 2023-01-10T16:58Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $MYGN (Myriad Genetics) 5.12% π $FOLD (Amicus Ther.) 5.23% π $VBIV (VBI Vaccines) 8.33% π Top [--] XBI Laggards: $DMTK (DermTech) -16.3% π» $BLUE (bluebird bio) -10.4% π» $BHVN (Biohaven Pharma) -6.7% π»"
X Link 2023-01-18T16:46Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $KALV (KalVista Pharma) 7.59% π $IOVA (Iovance BioTher.) 12.76% π $DMTK (DermTech) 21.24% π Top [--] XBI Laggards: $CPRX (Catalyst Pharma) -29.6% π» $RIGL (Rigel Pharma) -9.5% π» $VBIV (VBI Vaccines) -8.3% π»"
X Link 2023-01-23T20:33Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $OPK (OPKO Health) 6.98% π $GOSS (Gossamer Bio) 7.2% π $TGTX (TG Ther.) 10.11% π Top [--] XBI Laggards: $STOK (Stoke Ther.) -7.0% π» $PRTA (Prothena) -5.1% π» $KALV (KalVista Pharma) -4.0% π»"
X Link 2023-02-01T21:05Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $RLMD (Relmada Ther.) 5.91% π $RETA (Reata Pharma) 7.43% π $NKTR (Nektar Ther.) 8.46% π Top [--] XPH Laggards: $BMY (Bristol-Myers Squibb Co) -2.0% π» $TBPH (Theravance Biopharma) -1.6% π» $OCUL (Ocular Ther.) -1.0% π»"
X Link 2023-02-01T21:05Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $BBIO (BridgeBio Pharma) 13.1% π $CDNA (CareDx) 13.67% π $AKBA (Akebia Ther.) 40.15% π Top [--] XBI Laggards: $ALKS (Alkermes) -4.0% π» $NBIX (Neurocrine Bio) -4.0% π» $VRTX (Vertex Pharma) -4.0% π»"
X Link 2023-02-02T18:48Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $INBX (Inhibrx) 3.95% π $INO (Inovio Pharma) 5.87% π $AKBA (Akebia Ther.) 8.43% π Top [--] XBI Laggards: $TWST (Twist Bio) -17.7% π» $CCCC (C4 Ther.) -8.6% π» $BPMC (Blueprint Medicines) -6.5% π»"
X Link 2023-02-03T18:12Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $OCUL (Ocular Ther.) 3.3% π $ROIV (Roivant Sciences) 3.89% π $ACRS (Aclaris Ther.) 4.05% π Top [--] XPH Laggards: $AXSM (Axsome Ther.) -5.6% π» $OMER (Omeros) -4.2% π» $ELAN (Elanco Animal Health) -3.8% π»"
X Link 2023-02-03T18:12Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ACRS (Aclaris Ther.) 1.9% π $PRVB (Provention Bio) 3.38% π $ITCI (Intra-Cellular Therapies) 3.64% π Top [--] XPH Laggards: $AMRX (Amneal Pharma) -8.0% π» $NUVB (Nuvation Bio) -3.8% π» $SAVA (Cassava Sciences) -2.5% π»"
X Link 2023-02-09T16:45Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $ABBV (AbbVie) 2.06% π $RXDX (Prometheus Bio) 2.54% π $SRNE (Sorrento Ther.) 4.3% π Top [--] XBI Laggards: $ATRA (Atara BioTher.) -10.1% π» $GTHX (G1 Ther.) -6.8% π» $DMTK (DermTech) -6.3% π»"
X Link 2023-02-10T15:02Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $NKTR (Nektar Ther.) 4.78% π $AMRX (Amneal Pharma) 4.8% π $OCUL (Ocular Ther.) 39.79% π Top [--] XPH Laggards: $OMER (Omeros) -7.9% π» $ACRS (Aclaris Ther.) -5.1% π» $RETA (Reata Pharma) -5.0% π»"
X Link 2023-02-13T20:36Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $RXDX (Prometheus Bio) 4.91% π $SANA (Sana Biotech) 5.61% π $AKBA (Akebia Ther.) 5.61% π Top [--] XBI Laggards: $MGNX (Macrogenics) -23.5% π» $SRNE (Sorrento Ther.) -18.8% π» $OPK (OPKO Health) -5.2% π»"
X Link 2023-02-14T19:52Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ZTS (Zoetis) 6.22% π $ROIV (Roivant Sciences) 7.21% π $OCUL (Ocular Ther.) 14.82% π Top [--] XPH Laggards: $CARA (Cara Ther.) -5.1% π» $NKTR (Nektar Ther.) -2.9% π» $SAVA (Cassava Sciences) -2.8% π»"
X Link 2023-02-14T19:52Z [----] followers, [---] engagements
"π₯Companies with important clinical readouts Coming soonπ
$IVBXF IBI-325 (CD73 Binder) by Innovent Biologics in P1 - NCT05119998"
X Link 2023-02-14T20:04Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $RARE (Ultragenyx Pharma) 9.84% π $MGNX (Macrogenics) 20.15% π $ISEE (IVERIC bio) 23.9% π Top [--] XBI Laggards: $PRAX (Praxis Precision Medicines) -8.3% π» $ORGO (Organogenesis) -6.5% π» $IBRX (ImmunityBio) -5.1% π»"
X Link 2023-02-17T19:50Z [----] followers, [---] engagements
"π₯Companies with important clinical readouts Coming soonπ
$FGEN Pamrevlumab (CTGF Inhibitor) by FibroGen in P3 - NCT04371666 $AZN Tozorakimab (IL33 Inhibitor) by AstraZeneca in P2 - NCT04170543 $GSK Bepirovirsen (TLR8 Stimulant) by GlaxoSmithKline in P2 - NCT04676724"
X Link 2023-02-17T19:52Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $FULC (Fulcrum Ther.) 6.46% π $RLMD (Relmada Ther.) 7.7% π $RETA (Reata Pharma) 9.76% π Top [--] XPH Laggards: $ROIV (Roivant Sciences) -4.4% π» $AMRX (Amneal Pharma) -4.3% π» $OMER (Omeros) -2.2% π»"
X Link 2023-02-22T21:04Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $PRTA (Prothena) 6.6% π $AKBA (Akebia Ther.) 10.47% π $SRNE (Sorrento Ther.) nan% π Top [--] XBI Laggards: $CCCC (C4 Ther.) -16.9% π» $HRTX (Heron Ther.) -9.9% π» $VIR (Vir Biotech) -9.8% π»"
X Link 2023-02-24T16:51Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $RLMD (Relmada Ther.) 0.6% π $AMPH (Amphastar Pharma) 0.73% π $OMER (Omeros) 2.06% π Top [--] XPH Laggards: $FULC (Fulcrum Ther.) -52.6% π» $NKTR (Nektar Ther.) -45.9% π» $ROIV (Roivant Sciences) -4.4% π»"
X Link 2023-02-24T16:51Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $CLDX (Celldex Ther.) 10.52% π $SGMO (Sangamo Ther.) 14.29% π $SRNE (Sorrento Ther.) nan% π Top [--] XBI Laggards: $MGNX (Macrogenics) -4.5% π» $APLS (Apellis Pharma) -3.5% π» $AKBA (Akebia Ther.) -3.3% π»"
X Link 2023-02-27T18:00Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AXSM (Axsome Ther.) 4.63% π $ROIV (Roivant Sciences) 4.72% π $TBPH (Theravance Biopharma) 7.75% π Top [--] XPH Laggards: $RETA (Reata Pharma) -34.5% π» $NKTR (Nektar Ther.) -4.7% π» $FULC (Fulcrum Ther.) -4.1% π»"
X Link 2023-02-27T18:01Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ITCI (Intra-Cellular Therapies) 1.37% π $RLMD (Relmada Ther.) 1.97% π $CORT (Corcept Ther.) 9.77% π Top [--] XPH Laggards: $ACRS (Aclaris Ther.) -42.6% π» $NKTR (Nektar Ther.) -7.6% π» $AVIR (Atea Pharma) -4.4% π»"
X Link 2023-03-06T16:23Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ROIV (Roivant Sciences) 4.56% π $OCUL (Ocular Ther.) 8.24% π $ACRS (Aclaris Ther.) 8.77% π Top [--] XPH Laggards: $CARA (Cara Ther.) -29.9% π» $NKTR (Nektar Ther.) -4.9% π» $RETA (Reata Pharma) -4.3% π»"
X Link 2023-03-07T17:21Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $AKBA (Akebia Ther.) 14.01% π $RIGL (Rigel Pharma) 19.73% π $SRNE (Sorrento Ther.) nan% π Top [--] XBI Laggards: $GOSS (Gossamer Bio) -16.5% π» $BBIO (BridgeBio Pharma) -15.0% π» $IBRX (ImmunityBio) -6.4% π»"
X Link 2023-03-08T19:00Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AMPH (Amphastar Pharma) 0.45% π $PBH (Prestige Co) 0.61% π $ACRS (Aclaris Ther.) 1.44% π Top [--] XPH Laggards: $OMER (Omeros) -10.1% π» $PRVB (Provention Bio) -8.8% π» $AMRX (Amneal Pharma) -8.7% π»"
X Link 2023-03-10T19:30Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $MGNX (Macrogenics) 9.14% π $BLUE (bluebird bio) 9.35% π $SGEN (Seagen) 15.15% π Top [--] XBI Laggards: $IBRX (ImmunityBio) -6.2% π» $ACAD (ACADIA Pharma) -5.9% π» $ORGO (Organogenesis) -4.8% π»"
X Link 2023-03-13T13:40Z [----] followers, [---] engagements
"Promis Neurosciences to present new preclinical data for PMN310 at ADPD [----]. $ARFXF https://pryzm.ozmosi.com/product/25917 https://pryzm.ozmosi.com/product/25917"
X Link 2023-03-14T02:28Z [----] followers, [--] engagements
"$BMRN BioMarin to share updated data demonstrating commitment to understanding long-term benefit of VOXZOGO in children with Achondroplasia. More Info: #biotech #pharma https://pryzm.ozmosi.com/product/2395 https://pryzm.ozmosi.com/product/2395"
X Link 2023-03-14T16:48Z [----] followers, [---] engagements
"$IONC iOnctura announces pioneering research on drug candidate roginolisib highlighting unique biological features. More info: #Roginolisib #biotech #pharma https://pryzm.ozmosi.com/product/22041 https://pryzm.ozmosi.com/product/22041"
X Link 2023-03-16T18:16Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $OCGN (Ocugen) 9.66% π $MGNX (Macrogenics) 10.25% π $CPRX (Catalyst Pharma) 11.51% π Top [--] XBI Laggards: $GOSS (Gossamer Bio) -20.5% π» $KZR (Kezar Life Sciences) -14.4% π» $HALO (Halozyme Ther.) -8.4% π»"
X Link 2023-03-16T18:38Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $DMTK (DermTech) 8.54% π $MCRB (Seres Ther.) 10.93% π $IBRX (ImmunityBio) 36.3% π Top [--] XBI Laggards: $KRTX (Karuna Ther.) -11.6% π» $SWTX (SpringWorks Ther.) -8.6% π» $CLDX (Celldex Ther.) -6.1% π»"
X Link 2023-03-21T21:57Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AMRX (Amneal Pharma) 6.99% π $FULC (Fulcrum Ther.) 7.25% π $OMER (Omeros) 10.15% π Top [--] XPH Laggards: $ROIV (Roivant Sciences) -12.3% π» $NKTR (Nektar Ther.) -6.1% π» $ARVN (Arvinas) -4.4% π»"
X Link 2023-03-21T21:58Z [----] followers, [---] engagements
"$CDTX and $MLNT receive FDA approval for REZZAYO a treatment for candidemia and invasive candidiasis #Rezafungin More Info: #biotech #pharma https://pryzm.ozmosi.com/product/22082 https://pryzm.ozmosi.com/product/22082"
X Link 2023-03-22T21:29Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $JAZZ (Jazz Pharma) 1.7% π $PBH (Prestige Co) 1.71% π $CTLT (Catalent) 1.76% π Top [--] XPH Laggards: $RLMD (Relmada Ther.) -9.9% π» $ACRS (Aclaris Ther.) -4.7% π» $ROIV (Roivant Sciences) -3.9% π»"
X Link 2023-03-24T17:12Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $RIGL (Rigel Pharma) 7.6% π $AGEN (Agenus) 7.72% π $IOVA (Iovance BioTher.) 9.67% π Top [--] XBI Laggards: $HRTX (Heron Ther.) -6.5% π» $MRTX (Mirati Ther.) -4.9% π» $OCGN (Ocugen) -4.0% π»"
X Link 2023-03-27T17:46Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ANIP (ANI Pharma) 1.8% π $ROIV (Roivant Sciences) 4.04% π $ITCI (Intra-Cellular Therapies) 14.87% π Top [--] XPH Laggards: $HRMY (Harmony Biosciences) -27.3% π» $AXSM (Axsome Ther.) -4.7% π» $NKTR (Nektar Ther.) -3.9% π»"
X Link 2023-03-28T17:23Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $KRON (Kronos Bio) 5.77% π $EBS (Emergent BioSolutions) 11.44% π $ARCT (Arcturus Ther.) 13.58% π Top [--] XBI Laggards: $RNA (Avidity Bio) -17.9% π» $AKBA (Akebia Ther.) -5.6% π» $RIGL (Rigel Pharma) -4.9% π»"
X Link 2023-03-30T14:46Z [----] followers, [---] engagements
"$ESALY publishes additional detailed analyses from lecanemab phase 2b study. More Info: #biotech #pharma https://pryzm.ozmosi.com/product/16901 https://pryzm.ozmosi.com/product/16901"
X Link 2023-03-31T13:23Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $ALKS (Alkermes) 0.91% π $ITOS (ITeos Ther.) 0.97% π $HRTX (Heron Ther.) 7.58% π Top [--] XBI Laggards: $VBIV (VBI Vaccines) -46.3% π» $KZR (Kezar Life Sciences) -11.3% π» $STRO (Sutro Biopharma) -8.2% π»"
X Link 2023-04-04T16:17Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $RLMD (Relmada Ther.) 2.32% π $OMER (Omeros) 2.38% π $ITCI (Intra-Cellular Therapies) 3.42% π Top [--] XPH Laggards: $FULC (Fulcrum Ther.) -7.4% π» $AMRX (Amneal Pharma) -6.2% π» $NKTR (Nektar Ther.) -5.3% π»"
X Link 2023-04-04T16:17Z [----] followers, [---] engagements
"$MDGEF Medigene AG to present Phase I clinical data for MDG1011 with poster presentation at EBMT [----] Annual Meeting. More Info: #biotech #pharma https://pryzm.ozmosi.com/product/19741 https://pryzm.ozmosi.com/product/19741"
X Link 2023-04-11T17:06Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $RLMD (Relmada Ther.) 5.06% π $ARVN (Arvinas) 5.34% π $FULC (Fulcrum Ther.) 6.86% π Top [--] XPH Laggards: $CTLT (Catalent) -1.2% π» $PBH (Prestige Co) -0.1% π» $BMY (Bristol-Myers Squibb Co) 0.0% π»"
X Link 2023-04-13T14:21Z [----] followers, [---] engagements
"$HZN Horizon Therapeutics gets FDA approval to broaden TEPEZZA's use to all TED patients using Teprotumumab. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/7913 https://pryzm.ozmosi.com/product/7913"
X Link 2023-04-14T13:24Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $PCVX (Vaxcyte) 20.8% π $MORF (Morphic) 21.42% π $RXDX (Prometheus Bio) 69.28% π Top [--] XBI Laggards: $MRNA (Moderna) -8.8% π» $ALXO (ALX Oncology) -4.6% π» $OPK (OPKO Health) -1.9% π»"
X Link 2023-04-17T16:39Z [----] followers, [---] engagements
"$NUVL Nuvalent showcases promising preclinical results of NVL-655's intracranial activity at AACR Annual Meeting [----]. More Info: #NVL655 $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/25660 https://pryzm.ozmosi.com/product/25660"
X Link 2023-04-18T15:04Z [----] followers, [---] engagements
"Pharma/Biotech Recap: $ALZH: Alzheimer's treatment showcased. $ARDX: Ardelyx refiling application. $ASMB: Positive trial results. $COCP: Cocrystal shares results. $MDGL: Madrigal advances NASH. $SABS: Breakthrough flu treatment. $SLS: Trial Continuation Recommended. $YMAB: Y-mAbs presents Naxitamab. $NUVL: NVL-655 Promising Brain-Tumor Treatment $RPTX: AACR shows promise. $TRGNF: Cancer vaccine effective. $IMCR: ctDNA predicts survival. $TLSA: Foralumab for diabetes. $HUMA: Human vessels superior. $ERAS: Erasca trial promising. $ADAG: Promising Safe Efficacious. $CRBP: Virtual Expert"
X Link 2023-04-18T20:55Z [----] followers, [---] engagements
"$ACAD Acadia Pharmaceuticals announces presentation of Trofinetide clinical data and Rett Syndrome evidence at [----] AAN Meeting. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/2291 https://pryzm.ozmosi.com/product/2291"
X Link 2023-04-20T13:21Z [----] followers, [---] engagements
"$HZNP Horizon Therapeutics presents promising data on Inebilizumab for NMOSD at AAN Annual Meeting [----]. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/5291 https://pryzm.ozmosi.com/product/5291"
X Link 2023-04-20T13:21Z [----] followers, [---] engagements
"$WST $PVCT Provectus Biopharmaceuticals announces success of Rose Bengal against Colistin-Resistant Bacteria. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/7341 https://pryzm.ozmosi.com/product/7341"
X Link 2023-04-20T13:21Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $NUVB (Nuvation Bio) 2.63% π $FULC (Fulcrum Ther.) 5.28% π $OCUL (Ocular Ther.) 7.62% π Top [--] XPH Laggards: $ROIV (Roivant Sciences) -1.0% π» $NKTR (Nektar Ther.) -0.9% π» $AMRX (Amneal Pharma) -0.6% π»"
X Link 2023-04-21T13:46Z [----] followers, [---] engagements
"Pharma/Biotech Recap: $WST $PVCT: Rose Bengal Overcomes Resistance. $BGNE: Encouraging Trial Results. $DRMA: Dermata meets milestones. $SLS: GFH009 Phase I Completed. $AQST: FDA approves Anaphylm. $SNSE: Phase [--] approved. $PXXLF: Imeglimin presented orally"
X Link 2023-04-21T13:55Z [----] followers, [---] engagements
"Pharma/Biotech Highlights: $AXSM: Axsome presents SUNOSI. $ABBV: Triumph for atogepant. $CBAY: CymaBay's Seladelpar promising. $LIAN: LianBio's Mavacamten approved. $APLS: Pegcetacoplan marketing validated. $LXRX: LX9211 trial results"
X Link 2023-04-21T20:56Z [----] followers, [---] engagements
"$MDGEF Medigene AG shares promising results of MDG-1011 in Phase I study for high-risk blood cancers. Learn more about the TCR-T cell therapy at: More Info: #MDG1011 #BloodCancerTreatment $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/19741 https://pryzm.ozmosi.com/product/19741"
X Link 2023-04-25T13:18Z [----] followers, [--] engagements
"$OTSKY $SEPR Sunovion and Otsuka kick-off clinical trials for Ulotaront as potential treatment for Generalized Anxiety Disorder #drugnews #anxietytreatment More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/14866 https://pryzm.ozmosi.com/product/14866"
X Link 2023-04-26T13:59Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $GOSS (Gossamer Bio) 4.91% π $MORF (Morphic) 5.29% π $STOK (Stoke Ther.) 7.64% π Top [--] XBI Laggards: $VBIV (VBI Vaccines) -10.4% π» $ALKS (Alkermes) -5.7% π» $KDNY (Chinook Ther.) -5.1% π»"
X Link 2023-04-26T17:02Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $CTLT (Catalent) 3.41% π $OMER (Omeros) 3.94% π $PRVB (Provention Bio) nan% π Top [--] XPH Laggards: $ARVN (Arvinas) -7.0% π» $AMRX (Amneal Pharma) -4.1% π» $AMPH (Amphastar Pharma) -3.2% π»"
X Link 2023-04-27T15:17Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $KRON (Kronos Bio) 10.4% π $BLUE (bluebird bio) 23.1% π $IMGN (Immunogen) 24.19% π Top [--] XBI Laggards: $RNA (Avidity Bio) -12.0% π» $SGMO (Sangamo Ther.) -7.0% π» $STRO (Sutro Biopharma) -4.6% π»"
X Link 2023-04-28T16:56Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $CTLT (Catalent) 6.29% π $NGM (NGM Biopharma) 7.13% π $PRVB (Provention Bio) nan% π Top [--] XPH Laggards: $BMY (Bristol-Myers Squibb Co) -1.2% π» $RLMD (Relmada Ther.) -1.1% π» $AXSM (Axsome Ther.) -0.9% π»"
X Link 2023-04-28T16:57Z [----] followers, [---] engagements
"$MRVSY Minerva Neurosciences files NDA for Roluperidone a potential treatment for negative symptoms in schizophrenia. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/16270 https://pryzm.ozmosi.com/product/16270"
X Link 2023-05-01T13:19Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $INBX (Inhibrx) 10.17% π $ISEE (IVERIC bio) 15.32% π $TGTX (TG Ther.) 16.92% π Top [--] XBI Laggards: $DMTK (DermTech) -6.4% π» $AKBA (Akebia Ther.) -5.0% π» $ORGO (Organogenesis) -3.7% π»"
X Link 2023-05-01T16:03Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AMPH (Amphastar Pharma) 5.42% π $PCRX (Pacira BioSciences) 5.94% π $RLMD (Relmada Ther.) 6.71% π Top [--] XPH Laggards: $AMRX (Amneal Pharma) -4.4% π» $NUVB (Nuvation Bio) -1.9% π» $ROIV (Roivant Sciences) -1.3% π»"
X Link 2023-05-01T16:03Z [----] followers, [---] engagements
"$HZNP Horizon Therapeutics plc enrolls first patient in Phase [--] trial to evaluate the effectiveness of Daxdilimab in treating Lupus Nephritis. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/21539 https://pryzm.ozmosi.com/product/21539"
X Link 2023-05-02T14:07Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $PRTA (Prothena) 28.79% π $MDXG (MiMedx Group) 39.11% π $IMGN (Immunogen) 137.5% π Top [--] XBI Laggards: $UTHR (United Ther.) -4.2% π» $NBIX (Neurocrine Bio) -4.2% π» $AMGN (Amgen) -2.2% π»"
X Link 2023-05-03T18:39Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $FULC (Fulcrum Ther.) 4.01% π $RLMD (Relmada Ther.) 4.61% π $NGM (NGM Biopharma) 5.59% π Top [--] XPH Laggards: $PBH (Prestige Co) -3.9% π» $PRGO (Perrigo Co) -2.3% π» $CTLT (Catalent) -1.8% π»"
X Link 2023-05-05T16:45Z [----] followers, [---] engagements
"$PFE $ARVN Arvinas and Pfizer reveal plans to showcase Vepdegestrant (ARV-471) poster presentations at the [----] ESMO Breast Cancer Annual Congress. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/22165 https://pryzm.ozmosi.com/product/22165"
X Link 2023-05-08T13:08Z [----] followers, [---] engagements
"Pharma/Biotech Highlights: $PFE $ARVN: Arvinas Pfizer Poster. $MIST: Virtual KOL event. $TRVN: China approves OLINVYK. $RYTM: IMCIVREE approved: Weight Bardet-Biedl"
X Link 2023-05-08T20:25Z [----] followers, [---] engagements
"$MRVSY Minerva Neurosciences provides NDA update for Roluperidone a potential treatment for negative symptoms in schizophrenia. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/16270 https://pryzm.ozmosi.com/product/16270"
X Link 2023-05-10T14:16Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $KPTI (Karyopharm Ther.) 11.45% π $HALO (Halozyme Ther.) 11.87% π $MNKD (MannKind) 18.55% π Top [--] XBI Laggards: $ARQT (Arcutis BioTher.) -15.0% π» $EGRX (Eagle Pharma) -12.9% π» $INBX (Inhibrx) -7.4% π»"
X Link 2023-05-10T14:18Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $INVA (Innoviva) 2.85% π $AMPH (Amphastar Pharma) 4.5% π $OMER (Omeros) 6.0% π Top [--] XPH Laggards: $RETA (Reata Pharma) -23.1% π» $RVNC (Revance Ther.) -9.8% π» $NGM (NGM Biopharma) -4.3% π»"
X Link 2023-05-10T14:18Z [----] followers, [---] engagements
"Pharma/Biotech Highlights: $TAK: Takeda's effective treatments. $JAGX: Jaguar Health streamlines Mytesi access with AI portal. $ADXN: Addex epilepsy drug progresses. $PRTX: ELFABRIO FDA Approved. $IDRSF: Idorsia supports PTSD trial. $MRVSY: Roluperidone schizophrenia update"
X Link 2023-05-10T21:22Z [----] followers, [---] engagements
"$NUVL Nuvalent to release preliminary Phase [--] dose-escalation data for NVL-655; Q1 [----] financial results also reported. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/25660 https://pryzm.ozmosi.com/product/25660"
X Link 2023-05-11T13:39Z [----] followers, [---] engagements
"Pharma/Biotech Highlights: $PALI: Palisade Bio Doses. $SNGXW $SNGX: FDA Meeting Scheduled. $SAVA: Simufilam Alzheimer's trial complete. $RVPH: IND for Psoriasis. $LIAN: CAMZYOS approved in Macau. $ABEO: Abeona's EB-101 succeeds"
X Link 2023-05-11T20:35Z [----] followers, [---] engagements
"$NUVL: Nuvalent will share dosage updates and Q1 [----] results for NVL-655. $AIPT $PRAX: Promising Precision Medicine. $CYTK: CK-4021586 trial starts. $BLPH: Lung treatment success. $GERN: Geron Imetelstat Positive. $SWTX: Clinical data shared"
X Link 2023-05-11T20:35Z [----] followers, [---] engagements
"$RVVTF Revive Therapeutics updates on Phase [--] clinical study for Bucillamine in the treatment of COVID-19. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/299 https://pryzm.ozmosi.com/product/299"
X Link 2023-05-12T13:05Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $FDMT (4D Molecular Ther.) 7.99% π $RIGL (Rigel Pharma) 8.19% π $SRPT (Sarepta Ther.) nan% π Top [--] XBI Laggards: $HRTX (Heron Ther.) -36.3% π» $IBRX (ImmunityBio) -17.4% π» $EBS (Emergent BioSolutions) -14.9% π»"
X Link 2023-05-12T16:18Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $OMER (Omeros) 1.46% π $AMPH (Amphastar Pharma) 1.46% π $INVA (Innoviva) 1.93% π Top [--] XPH Laggards: $ANIP (ANI Pharma) -10.1% π» $SAVA (Cassava Sciences) -7.0% π» $SUPN (Supernus Pharma) -5.1% π»"
X Link 2023-05-12T16:18Z [----] followers, [---] engagements
"π₯Companies with important clinical readouts Coming soonπ
$BMY BMS-986278 (LPA1 Antagonist) by Bristol-Myers Squibb in P1 - NCT05805904 $IVBXF GFH-925 (KRA G12C Inhibitor) by Innovent Biologics in P1 - NCT05504278"
X Link 2023-05-12T16:19Z [----] followers, [---] engagements
"$NGENF NervGen Pharma updates on their Q1 [----] results and clinical trials of NVG-291 More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/23953 https://pryzm.ozmosi.com/product/23953"
X Link 2023-05-15T13:18Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $CARA (Cara Ther.) 1.87% π $ARVN (Arvinas) 2.37% π $AMPH (Amphastar Pharma) 2.9% π Top [--] XPH Laggards: $ATHA (Athira Pharma) -3.7% π» $RVNC (Revance Ther.) -2.4% π» $OMER (Omeros) -1.6% π»"
X Link 2023-05-15T14:42Z [----] followers, [---] engagements
"Pharma/Biotech Highlights: $NBIX: INGREZZA provides stability. $CKPT: TILT cancer trial. $PXXLF: TWYMEEG (Imeglimin) sales reported. $ORTX: Orchard reports Q1 submits biologics license. $MRK: Collaboration for lung cancer testing. $TARA: Bladder cancer trial"
X Link 2023-05-15T22:39Z [----] followers, [----] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $AMPH (Amphastar Pharma) 3.9% π $ANIP (ANI Pharma) 8.59% π $CARA (Cara Ther.) 10.6% π Top [--] XPH Laggards: $RLMD (Relmada Ther.) -5.5% π» $NKTR (Nektar Ther.) -5.3% π» $SAVA (Cassava Sciences) -4.9% π»"
X Link 2023-05-16T18:44Z [----] followers, [---] engagements
"$BGNE The Max Foundation BeiGene and the BeiGene Foundation collaborate to bring BRUKINSA (Zanubrutinib) for the treatment of chronic lymphocytic leukemia to lowand middle-income countries advancing health equity. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/14225 https://pryzm.ozmosi.com/product/14225"
X Link 2023-05-17T23:13Z [----] followers, [---] engagements
"Pharma/Biotech Highlights: $MIRM: Mirum to present LIVMARLI data at ESPGHAN. $ARDX: FDA reviews Tenapanor. $TLSA: Foralumab presentation scheduled. $IMMP: Combination shows promise. $IMUX: MS drug activates Nurr1. $RHHBY: Effective MS treatment"
X Link 2023-05-18T02:04Z [----] followers, [---] engagements
"$ABBV: Positive perception Rinvoq. $BGNE: BRUKINSA treatment access. $OPT: Opthea Market Discussion. $GH: Insurance covers Guardant360. $PTCT: PTC's Successful Trial. $TCRX: TScan shares clinical results. $IPSEY: Bylvay rare liver. $CRVS: Corvus presents CPI-818"
X Link 2023-05-18T02:04Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $RIGL (Rigel Pharma) 9.23% π $VXRT (Vaxart) 14.62% π $ICPT (Intercept Pharma) nan% π Top [--] XBI Laggards: $BEAM (Beam Ther.) -2.0% π» $TGTX (TG Ther.) -1.5% π» $TWST (Twist Bio) -1.4% π»"
X Link 2023-05-19T14:10Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $NGM (NGM Biopharma) 3.98% π $NKTR (Nektar Ther.) 6.72% π $CTLT (Catalent) 15.09% π Top [--] XPH Laggards: $AXSM (Axsome Ther.) -2.0% π» $CARA (Cara Ther.) -1.3% π» $SAVA (Cassava Sciences) -0.7% π»"
X Link 2023-05-19T14:10Z [----] followers, [---] engagements
"$RYTM Rhythm Pharmaceuticals and Genpharm join forces to offer Setmelanotide drug to patients in GCC countries. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/2000 https://pryzm.ozmosi.com/product/2000"
X Link 2023-05-22T13:08Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $OMER (Omeros) 6.07% π $ARVN (Arvinas) 8.27% π $AVIR (Atea Pharma) 35.0% π Top [--] XPH Laggards: $FULC (Fulcrum Ther.) -3.4% π» $SUPN (Supernus Pharma) -1.6% π» $AXSM (Axsome Ther.) -1.2% π»"
X Link 2023-05-22T16:53Z [----] followers, [---] engagements
"$ESALY Advanced Infusion Care (AIC) now providing LEQEMBI (Lecanemab-irmb) monoclonal antibody infusion therapy announced Eisai pharmaceuticals More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/16901 https://pryzm.ozmosi.com/product/16901"
X Link 2023-05-23T16:03Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $DMTK (DermTech) 14.58% π $IOVA (Iovance BioTher.) 15.96% π $SGMO (Sangamo Ther.) 16.91% π Top [--] XBI Laggards: $RIGL (Rigel Pharma) -6.5% π» $VXRT (Vaxart) -2.8% π» $CYTK (Cytokinetics) -2.8% π»"
X Link 2023-05-23T16:08Z [----] followers, [---] engagements
"$BOVNF $TRGNF Transgene and BioInvent report positive results in Phase Ia trial of oncolytic virus BT-001 for solid tumors. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/22617 https://pryzm.ozmosi.com/product/22617"
X Link 2023-05-25T13:55Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $OCGN (Ocugen) 2.06% π $PTGX (Protagonist Ther.) 2.19% π $TWST (Twist Bio) 2.74% π Top [--] XBI Laggards: $BTAI (BioXcel Ther.) -28.4% π» $AKBA (Akebia Ther.) -15.0% π» $MRTX (Mirati Ther.) -13.3% π»"
X Link 2023-05-25T16:55Z [----] followers, [---] engagements
"$IVEVF $SBMFF Inventiva's partner Sino Biopharm receives IND approval from NMPA for clinical trial of Lanifibranor in China More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/19858 https://pryzm.ozmosi.com/product/19858"
X Link 2023-05-25T20:36Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $CGEM (Cullinan Oncology) 12.34% π $ITOS (ITeos Ther.) 20.55% π $RCUS (Arcus Bio) 25.71% π Top [--] XBI Laggards: $BTAI (BioXcel Ther.) -7.3% π» $ATRA (Atara BioTher.) -5.5% π» $SWTX (SpringWorks Ther.) -3.8% π»"
X Link 2023-05-26T15:08Z [----] followers, [---] engagements
"$NBIO Nascent Biotech takes back global control of Pritumumab More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/7047 https://pryzm.ozmosi.com/product/7047"
X Link 2023-05-26T21:47Z [----] followers, [---] engagements
"$RVVTF Revive Therapeutics provides latest update on Phase [--] Clinical Study for Bucillamine in COVID-19 treatment. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/299 https://pryzm.ozmosi.com/product/299"
X Link 2023-05-30T13:05Z [----] followers, [---] engagements
"$ITCI Intra-Cellular Therapies reveals data presentations at the American Society of Clinical Psychopharmacology Annual Meeting. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/1273 https://pryzm.ozmosi.com/product/1273"
X Link 2023-05-31T14:12Z [----] followers, [--] engagements
"$SELB Selecta Biosciences presents positive data from Phase [--] DISSOLVE Program of SEL-212 in Chronic Refractory Gout at EULAR [----] More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/15493 https://pryzm.ozmosi.com/product/15493"
X Link 2023-05-31T14:12Z [----] followers, [---] engagements
"Pharma/Biotech Highlights: $NTLA: Intellia presents HAE treatment findings. $TENX $MIST: Tenax patents TNX-103 for pulmonary hypertension. $ITCI: CAPLYTA data presentation. $AGNPF: Algernon Pharma patents. $TGTX: BRIUMVI MS Data. $SELB: SEL-212 data shared"
X Link 2023-05-31T20:24Z [----] followers, [----] engagements
"$PHGE: BiomX presenting BX004 data. $TNXP: Tonix presents research. $MRKR: Marker Therapeutics: Promising Pre-clinical Data. $ATNM: RayzeBio advances treatment. $COCP: Cocrystal approved COVID-19 study. $CLDX: Celldex tests CDX-585 on advanced cancer"
X Link 2023-05-31T20:24Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $RGNX (Regenxbio) 8.24% π $ALXO (ALX Oncology) 9.0% π $BHVN (Biohaven Pharma) 20.39% π Top [--] XBI Laggards: $INO (Inovio Pharma) -3.6% π» $ABBV (AbbVie) -2.9% π» $ALEC (Alector) -2.8% π»"
X Link 2023-06-01T15:43Z [----] followers, [---] engagements
"$DBTX Decibel Therapeutics to showcase DB-020 phase 1b clinical trial results at ASCO [----] Annual Meeting More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/26987 https://pryzm.ozmosi.com/product/26987"
X Link 2023-06-01T20:37Z [----] followers, [--] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ARVN (Arvinas) 3.68% π $PAHC (Phibro Animal Health) 3.72% π $ELAN (Elanco Animal Health) 4.01% π Top [--] XPH Laggards: $COLL (Collegium Pharma) -3.1% π» $CARA (Cara Ther.) -1.8% π» $TBPH (Theravance Biopharma) -1.2% π»"
X Link 2023-06-02T15:16Z [----] followers, [---] engagements
"$GERN Geron's Imetelstat presents promising results in IMerge Phase [--] trial showing durable transfusion independence in Lower Risk MDS patients at ASCO presentation More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/1069 https://pryzm.ozmosi.com/product/1069"
X Link 2023-06-02T21:14Z [----] followers, [---] engagements
"$LTUS NRx Pharmaceuticals teams up with Lotus Pharmaceuticals and Alvogen Inc. to advance development and sales of NRX-101 drug. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/16388 https://pryzm.ozmosi.com/product/16388"
X Link 2023-06-05T13:12Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $GTHX (G1 Ther.) 7.64% π $REPL (Replimune Group) 12.06% π $PRAX (Praxis Precision Medicines) 13.79% π Top [--] XBI Laggards: $EGRX (Eagle Pharma) -9.7% π» $BPMC (Blueprint Medicines) -9.2% π» $RCUS (Arcus Bio) -8.9% π»"
X Link 2023-06-05T14:03Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $RVNC (Revance Ther.) 2.82% π $FULC (Fulcrum Ther.) 2.93% π $CARA (Cara Ther.) 5.1% π Top [--] XPH Laggards: $PBH (Prestige Co) -3.8% π» $COLL (Collegium Pharma) -3.0% π» $AMPH (Amphastar Pharma) -2.0% π»"
X Link 2023-06-05T14:03Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $OCUL (Ocular Ther.) 3.04% π $ROIV (Roivant Sciences) 3.34% π $ATHA (Athira Pharma) 3.65% π Top [--] XPH Laggards: $RLMD (Relmada Ther.) -2.1% π» $RVNC (Revance Ther.) -1.9% π» $MRK (Merck & Co) -1.1% π»"
X Link 2023-06-06T14:53Z [----] followers, [---] engagements
"Pharma/Biotech Highlights: $AGNPF: Algernon to present Ifenprodil Cough results. $MRK: FDA approves PREVYMIS to prevent CMV. $RIGL: Rigel's Olutasidenib published in Blood Advances. $TRGNF: Cancer vaccine generates response against carcinoma"
X Link 2023-06-07T01:57Z [----] followers, [---] engagements
"$CBAY CymaBay to Unveil New Primary Biliary Cholangitis Data for Seladelpar at International Liver Congress [----]. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/19328 https://pryzm.ozmosi.com/product/19328"
X Link 2023-06-07T13:07Z [----] followers, [--] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $RIGL (Rigel Pharma) 4.64% π $DMTK (DermTech) 5.58% π $OPK (OPKO Health) 7.23% π Top [--] XBI Laggards: $VXRT (Vaxart) -26.8% π» $FGEN (FibroGen) -5.4% π» $IONS (Ionis Pharma) -5.1% π»"
X Link 2023-06-07T13:49Z [----] followers, [---] engagements
"$ARVN Arvinas' ARV-766 shows promising signals of efficacy in late-line mCRPC including patients with AR L702H mutations as per interim data from Phase 1/2 dose escalation and expansion trial. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/23550 https://pryzm.ozmosi.com/product/23550"
X Link 2023-06-08T13:25Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $IMGN (Immunogen) 5.37% π $TGTX (TG Ther.) 5.98% π $FDMT (4D Molecular Ther.) 11.55% π Top [--] XBI Laggards: $KZR (Kezar Life Sciences) -12.7% π» $EDIT (Editas Medicine) -10.1% π» $FATE (Fate Ther.) -7.1% π»"
X Link 2023-06-08T15:09Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ATHA (Athira Pharma) 1.39% π $MRK (Merck & Co) 1.44% π $LLY (Eli Lilly and Co) 1.69% π Top [--] XPH Laggards: $NGM (NGM Biopharma) -8.6% π» $ROIV (Roivant Sciences) -5.3% π» $CTLT (Catalent) -4.9% π»"
X Link 2023-06-08T15:09Z [----] followers, [---] engagements
"The FDA is expected to give full approval of Alzheimers drug Leqembi. That's good news for patients but if they could get tested proactively before Alzheimer's symptoms appear even more patients could benefit. $BIIB $ESAIY #Alzheimers #FDA https://buff.ly/3WUIYFI https://buff.ly/3WUIYFI"
X Link 2023-06-08T15:39Z [----] followers, [---] engagements
"$CLDX Celldex Therapeutics to showcase promising results of Barzolvolimab at EAACI [----] More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/22094 https://pryzm.ozmosi.com/product/22094"
X Link 2023-06-08T20:31Z [----] followers, [---] engagements
"𧬠SPDR Biotech $XBI Movers Today π©Έ Top [--] XBI Gainers: $HRTX (Heron Ther.) 4.62% π $IMGN (Immunogen) 7.46% π $BIIB (Biogen) nan% π Top [--] XBI Laggards: $KROS (Keros Ther.) -11.7% π» $FGEN (FibroGen) -8.0% π» $NRIX (Nurix Ther.) -6.5% π»"
X Link 2023-06-09T15:42Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $ROIV (Roivant Sciences) 2.97% π $AMRX (Amneal Pharma) 3.96% π $NGM (NGM Biopharma) 4.51% π Top [--] XPH Laggards: $ATHA (Athira Pharma) -5.6% π» $RPRX (Royalty Pharma) -4.3% π» $RLMD (Relmada Ther.) -4.3% π»"
X Link 2023-06-09T15:43Z [----] followers, [---] engagements
"$GERN Geron reports encouraging results for Imetelstat in treating lower risk MDS patients with evidence of disease-modifying activity and favorable fatigue PRO. More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/1069 https://pryzm.ozmosi.com/product/1069"
X Link 2023-06-12T13:08Z [----] followers, [---] engagements
"π SPDR Pharma $XPH Movers Today π Top [--] XPH Gainers: $SAVA (Cassava Sciences) 5.08% π $ARVN (Arvinas) 5.9% π $CTLT (Catalent) 10.85% π Top [--] XPH Laggards: $OMER (Omeros) -8.3% π» $ROIV (Roivant Sciences) -2.9% π» $TBPH (Theravance Biopharma) -2.6% π»"
X Link 2023-06-12T14:06Z [----] followers, [---] engagements
"Aardvark Therapeutics reveals encouraging results from Phase II clinical trial for ARD-101 drug More Info: $XBI $IBB $XPH $PPH https://pryzm.ozmosi.com/product/24702 https://pryzm.ozmosi.com/product/24702"
X Link 2023-06-12T16:16Z [----] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing